N.O.max ER

Suggested/Recommended/Usage/Directions

Directions: Take three tablets twice per day: 3 tablets 30 minutes before breakfast and 3 tablets again 30 minutes before lunch with 8 ounces of water.

Formulation re: Other

N.O. max ER represents an extended-release nitric oxide precursor. Scientists now refer to nitric oxide (NO) as the "foundation" of cardiovascular health. This tiny molecule is a vasodilator responsible for controlling blood flow to the entire body, which may help support healthy blood flow pressure and promote the health of the endothelium-the inside of blood vessels. With age comes diminished NO levels; that's why since 1998, when three scientists won the Nobel Prize for their discovery of NO, researchers have been working to harness its heart-healthy activity. Today, with the application of XYMOGEN's extended-release technology, that activity has been realized with N.O. max ER.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Precautions re: Pregnant or Nursing or Prescription Medications

Cautions: Consult your healthcare professional prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.

Precautions re: Children

Keep out of reach of children. This product is not intended for use by individuals under 18 years of age.

Precautions re: All Other

Do not use if tamper seal is damaged.

Storage

Storage: Keep closed in a cool, dry place out of reach of children.

Precautions re: Children

Storage: Keep closed in a cool, dry place out of reach of children.

Formulation re: Does NOT Contain

Formulated to Exclude: Wheat, gluten, yeast, soy, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Formula re: Contains

Extended-Release Arginine Alpha-Ketoglutarate Clinically-Tested Ingredient

FDA Statement of Identity

Dietary Supplement

Brand IP Statement(s) re: (c), (TM), (SM)

Xymogen Exclusive Professional Formulas

Seals/Symbols

ePV (ePedigree Verification) Third-Party Verified GMP Compliant

Brand IP Statement(s) re: (c), (TM), (SM)

Actinos S1. ActiNOS is a trademark of Glanbia pIc. Copyright 2022 Xymogen

Precautions re: Allergies

Contains: Milk

General Statements: All Other Content

Scan to Learn More! This package is completely recyclable

Precautions re: Allergies

Cautions: Consult your healthcare professional prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.